• Home
  • About
  • Research
    • Founder
    • Round Table
    • Frontier Researchers/Clinicians
    • Scientific partners
  • CUTTING-EDGE MEETINGS
  • NOT TO MISS
  • Events & News
  • Videogallery
  • Contact Us
  • About Me


    The first International ReGenera R&D International for Aging Intervention and VCC Preventive Medical Promotion Foundation has been a flashy success.

    It has been held in Beijing last June 8, having as topics Gut Microbiota and Health. The keynote speaker was prof. Marotta and the meeting features the most authoritative Asian specialists in the field.

    The conference room was fully packed and, most important, about 10.000 physicians and health professionals registered for a live attendance at distance.

    The event as covered by the most reputed national TV channels and in the next days a series of interviews followed up.

    The organizer, VCC Preventive Medical Promotion Foundation, given this success, is planning further similar top scientific gatherings this year in other locations.

    There was a general consensus on the importance to deepen our knowledge in this area as well ass starting providing practical steps forwards an evaluation and phenotypic monitoring of gut microbiota, while envisaging designer pro-prebiotics interventions.

  • Home
  • About
  • Research
    • Founder
    • Round Table
    • Frontier Researchers/Clinicians
    • Scientific partners
  • CUTTING-EDGE MEETINGS
  • NOT TO MISS
  • Events & News
  • Videogallery
  • Contact Us

THE HIDDEN PHENOMENON OF OXIDATIVE STRESS DURING TREATMENT OF SUBCLINICAL-MILD HYPOTHYROIDISM: A PROTECTIVE NUTRACEUTICAL INTERVENTION.

September 24, 2013
Tomella C, Catanzaro R, Illuzzi N, Cabeca A, Zerbinati N, Celep G, Milazzo M, Sapienza C, Italia A, Lorenzetti A, Marotta F.

Source

ReGenera Research group for Aging Intervention, Milano, Italy

 

Abstract

Recent studies suggest that subjects with hypothyroidism under therapy with L-T4 might develop oxidative stress. The aim of this study was to test a redox-balance modulator, FPP, together with subclinical (SH) or mild hypothyroidism (MH) treatment in view of biochemical changes. 60 females treated for SH-MH were divided into two matched groups and received either FPP 3gr 1 sachet t.i.d. or placebo for 3 months. A significant baseline increase of all oxidative markers was observed in SH-MH (p<0.05 vs control) and even more under T4 treatment (p<0.05). FPP caused a normalization of redox markers (p<0.01 vs placebo). Thyroid supplementation accelerates mitochondrial oxygen consumption and oxidative stress while a redox-modulator therapy is advisable, given the long-lasting treatment in such cases.

PMID: 24050492 [PubMed – as supplied by publisher]
Share

Events & News

  • About ReGenera


    The first International ReGenera R&D International for Aging Intervention and VCC Preventive Medical Promotion Foundation has been a flashy success.

    It has been held in Beijing last June 8, having as topics Gut Microbiota and Health. The keynote speaker was prof. Marotta and the meeting features the most authoritative Asian specialists in the field.

    The conference room was fully packed and, most important, about 10.000 physicians and health professionals registered for a live attendance at distance.

    The event as covered by the most reputed national TV channels and in the next days a series of interviews followed up.

    The organizer, VCC Preventive Medical Promotion Foundation, given this success, is planning further similar top scientific gatherings this year in other locations.

    There was a general consensus on the importance to deepen our knowledge in this area as well ass starting providing practical steps forwards an evaluation and phenotypic monitoring of gut microbiota, while envisaging designer pro-prebiotics interventions.

  • Error: Please check if you enter Instagram username and Access Token in Theme Setting > Social Profiles
  • Follow Me On



    • Recent Posts

      • New Focus Area
        January 12, 2023
      • The Wellity Institute
        January 12, 2023
      • New Research Highlight
        September 16, 2021

    © 2019 by ReGenera R&D - Imternational for aging intervention